Skip to Content

TRC-00412 | HER2 mab (Human) ELISA Kit | 96 Well

Product Overview

A sandwich ELISA kit for the quantitative measurement of HER2 mab in Human serum and plasma.

Trastuzumab (Herclon®, Herceptin®) is a recombinant DNA-derived humanized monoclonal antibody that selectively targets the extracellular domain of the human epidermal growth factor receptor 2 protein (HER2). Trastuzumab has antitumor activity against HER2-positive human breast tumor cells in laboratory models and is active for the trea™ent of women with HER2-overexpressing breast cancers. This antibody was approved in 1998 for clinical use for HER2 overexpressing metastatic breast cancer. In HER2 overexpressing cells, trastuzumab markedly down-regulates HER2 expression by accelerating receptor endocytosis and degradation and inhibits cell cycle progression by inducing the formation of p27Kip1/Cdk2 complexes. Trastuzumab ELISA kit has been developed for specific quantification of Trastuzumab concentration in human serum or plasma with high sensitivity and reproducibility.

Assay Information

Assay FormatSandwich ELISA
Species ReactivityHuman
Sample TypeHuman serum and plasma
Detection MethodAbsorbance (450 nm)
Detection Wavelength450 nm
Kit Size96 Well

Performance Data

Detection Range11 - 300 ng/ml
SensitivityQuantitative limit: 11 ng/ml, Detection limit: 2 ng/ml
Detection Limit2 ng/ml

Applications

This ELISA kit is used for quantitative measurement of Trastuzumab in human serum and plasma

Features & Benefits

  • Designed for quantitative measurement of HER2 mab.
  • Assay format: Sandwich ELISA.
  • Sample type: Human serum and plasma.
  • Detection method: Absorbance (450 nm).
  • Detection Range: 11 - 300 ng/ml
  • Sensitivity: Quantitative limit: 11 ng/ml, Detection limit: 2 ng/ml
  • Kit size: 96 Well.

Storage & Shipping

Storage+4°C
ShippingGel Pack
Shelf Life12 Months

Product Details

Catalog NumberTRC-00412
Analyte / TargetHER2 mab